Cargando…

New Rising Infection: Human Herpesvirus 6 Is Frequent in Myeloma Patients Undergoing Autologous Stem Cell Transplantation after Induction Therapy with Bortezomib

Herpesvirus 6 (HHV-6) infection is a common complication during immunosuppression. Its significance for multiple myeloma (MM) patients undergoing autologous stem cell transplantation (ASCT) after treatment with novel agents affecting immune system remains undetermined. Data on 62 consecutive MM pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horowitz, Netanel, Oren, Ilana, Lavi, Noa, Zuckerman, Tsila, Benyamini, Noam, Kra-Oz, Zipi, Held, Viki, Avivi, Irit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517825/ https://www.ncbi.nlm.nih.gov/pubmed/23243510 http://dx.doi.org/10.1155/2012/409765

Ejemplares similares

Dendritic Cell Cancer Vaccines: From the Bench to the Bedside
por: Katz, Tamar, et al.
Publicado: (2014)

P1543: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH HEMATOLOGICAL MALIGNANCIES THAT NEED VASOACTIVE SUPPORT – SINGLE CENTER STUDY
por: Vitkon, Roy, et al.
Publicado: (2023)

Lower Patient Anxiety and Unchanged Levels of Adherence to Hemato-Oncologic Treatment in Response to New Measures to Reduce Hospital Exposure Risk to COVID-19
por: Sarid, Nadav, et al.
Publicado: (2021)

Hematopoietic Stem Cell Transplantation—50 Years of Evolution and Future Perspectives
por: Henig, Israel, et al.
Publicado: (2014)

Real‐world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study
por: Shragai, Tamir, et al.
Publicado: (2022)

Pathogenesis and prognostication in acute lymphoblastic leukemia
por: Zuckerman, Tsila, et al.
Publicado: (2014)

The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission—A retrospective multicenter study
por: Shargian, Liat, et al.
Publicado: (2022)

Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study
por: Vitkon, Roy, et al.
Publicado: (2021)

Affinity- and Specificity-Enhancing Mutations Are Frequent in Multispecific Interactions between TIMP2 and MMPs
por: Sharabi, Oz, et al.
Publicado: (2014)

The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation
por: Henig, Israel, et al.
Publicado: (2020)

Fusion of piggyBac-like transposons and herpesviruses occurs frequently in teleosts
por: Inoue, Yusuke, et al.
Publicado: (2018)

Discovery of tumoricidal DNA oligonucleotides by response-directed in vitro evolution
por: Mamet, Noam, et al.
Publicado: (2020)

COVID-19 in patients with lymphoproliferative diseases during the Omicron variant surge
por: Bronstein, Yotam, et al.
Publicado: (2022)

Out of Sight, but Not Out of Mind: Aspects of the Avian Oncogenic Herpesvirus, Marek’s Disease Virus
por: Davidson, Irit
Publicado: (2020)

Bortezomib
por: Rajappa, Senthil
Publicado: (2010)

The rising incidence of severe sepsis based on administrative data — real change or coding-driven bias?
por: Oud, Lavi
Publicado: (2015)

Human herpesvirus 6 reactivation and delirium are frequent and associated events after cord blood transplantation
por: Hill, Joshua A, et al.
Publicado: (2015)

Progress on the Application of Bortezomib and Bortezomib-Based Nanoformulations
por: Liu, Jianhao, et al.
Publicado: (2021)

Depletion of B cells rejuvenates the peripheral B‐cell compartment but is insufficient to restore immune competence in aging
por: Avivi, Irit, et al.
Publicado: (2019)

Does Gender Matter in Non-Hodgkin Lymphoma? Differences in Epidemiology, Clinical Behavior, and Therapy
por: Horesh, Nurit, et al.
Publicado: (2014)

Calreticulin Mutations in Myeloproliferative Neoplasms
por: Lavi, Noa
Publicado: (2014)

Enrichment of milk with magnesium provides healthier and safer dairy products
por: Ben-Ishay, Noa, et al.
Publicado: (2017)

Abnormal adipogenic signaling in the bone marrow mesenchymal stem cells contributes to supportive microenvironment for leukemia development
por: Sabbah, Rawan, et al.
Publicado: (2023)

The generation of diversity: clonal selection theory and the rise of molecular immunology
por: Löwy, Ilana
Publicado: (1999)

Third BNT162b2 mRNA SARS-CoV-2 Vaccine Dose Significantly Enhances Immunogenicity in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
por: Henig, Israel, et al.
Publicado: (2023)

Patterns of human herpesvirus-8 oral shedding among diverse cohorts of human herpesvirus-8 seropositive persons
por: Bender Ignacio, Rachel A., et al.
Publicado: (2016)

Bortezomib in Kidney Transplantation
por: Raghavan, Rajeev, et al.
Publicado: (2010)

STK405759 as a combination therapy with bortezomib or dexamethasone, in in vitro and in vivo multiple myeloma models
por: Rozic, Gabriela, et al.
Publicado: (2018)

CD-tagging-MS2: detecting allelic expression of endogenous mRNAs and their protein products in single cells
por: Sheinberger, Jonathan, et al.
Publicado: (2017)

Kaposi sarcoma associated herpesvirus (KSHV) induces AKT hyperphosphorylation, bortezomib-resistance and GLUT-1 plasma membrane exposure in THP-1 monocytic cell line
por: Gonnella, Roberta, et al.
Publicado: (2013)

Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance
por: Kraus, M, et al.
Publicado: (2013)

Herpesvirus
por: Kradin, Richard L., et al.
Publicado: (2013)

Predictors of Early and Late Mortality for Patients with Hematologic Malignancy and Invasive Mold Disease
por: Yashphe, Eva L., et al.
Publicado: (2021)

PB2288: INCIDENCE OF NEWLY DIAGNOSED AGGRESSIVE NON-HODGKIN’S LYMPHOMA BEFORE AND DURING THE COVID-19 PANDEMIC IN ISRAEL - A SINGLE CENTER RETROSPECTIVE STUDY
por: Bronstein, Yotam, et al.
Publicado: (2023)

Bortezomib in the management of multiple myeloma
por: Laubach, Jacob P, et al.
Publicado: (2009)

An Overview of Bortezomib-Induced Neurotoxicity
por: Meregalli, Cristina
Publicado: (2015)

Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study
por: Ram, Ron, et al.
Publicado: (2021)

Remote Digital Microscopy Improves Hematology Laboratory Workflow by Reducing Peripheral Blood Smear Analysis Turnaround Time
por: Katz, Ben-Zion, et al.
Publicado: (2022)

Humoral serological response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies
por: Gurion, Ronit, et al.
Publicado: (2021)

Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma
por: O’Connor-Byrne, N., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_99i6lod2jjljgqnb1t3qrrddpp